Abstract:There have been many literatures reporting the binding performance of transition metal complexes towards DNA, aiming at anti-cancer and anti-tumor drugs. However, most of these references focused on divalent transition metal cations, such as Co(II), Ni(II), Cu(II) and Zn(II). Only a few efforts have been devoted to high-valent transition metal cations. In this paper, we synthesized two Co(II) and Co(III) complexes, tris{2-(pyridin-2-yl)benzo[d]imidazole-1-ide}-cobalt(III) [denoted as Co(L)3] and bis{2-(pyridin-2-yl)benzo[d]imidazole-1-ide}-{2-(pyridin-2-yl)-1H-benzo[d]imidazole}-cobalt(II) [denoted as Co(HL)(L)2], using a diamine ligand 2-(pyridin-2-yl)-1H-benzo[d]imidazole (denoted as HL). Their molecular structure was identified with their single crystals, MS and NMR spectra. Co(L)3 and Co(HL)(L)2 share the same crystal system (monoclinic) and space group (P21/c). Their crystal cell parameters were found rather similar to each other owing to their rather similar ligands, showing a slightly distorted octahedron coordination geometry. No intramolecular interaction, superamolecular interactions and π-π staking between neighboring Co(L)3 molecules or neighboring Co(HL)(L)2 molecules were found, forming a clean coordination environment. Density functional theory calculation on their single crystals suggested that they had similar onset electronic transitions. Their thermal stability, absorption and emission were compared. Owing to their rather similar molecular structures, most of their features were similar. Their binding performance for calf thymus DNA (CT-DNA) was then analyzed and compared. The binding mode between two Co complexes and CT-DNA was analyzed and confirmed by means of viscosity monitoring, circular dichroism analysis, SEM and XRD comparison. Their binding constants were determined as 974.89 M-1 for Co(L)3 and 829.25 M-1 for Co(HL)(L)2, respectively. We found a hydrogen bond between Co(L)3 and CH3OH. No hydrogen bonds were found in Co(HL)(L)2. This result suggested that the Co(L)3 interact with Ct-DNA via the combination of hydrogen bond and weak intermolecular interaction with DNA, while Co(HL)(L)2 interacts with Ct-DNA via only weak intermolecular interaction with DNA. These values were two fold higher than those of literature values (<450 M−1), indicating their potential for DNA treatment.

Crystal Structure,Interaction with DNA and BSA and Antiproliferative Activities of Cobalt(Ⅱ) Complex with Demethylcantharate and 2-Aminopyridine

Crystal structure, DNA interaction, and antiproliferative activity of the cobalt(II) complex of demethylcantharate and imidazole

Crystal Structure, Interaction with DNA, and Bovine Serum Albumin of the Cobalt(ii) Complex of Demethylcantharate and 2,2′-Bipyridine

Crystal Structures, Interactions with Biomacromolecules and Anticancer Activities of Mn(II), Ni(II), Cu(II) Complexes of Demethylcantharate and 2-Aminopyridine

Crystal Structures, Dna Interaction and Growth Inhibitory Activities of the Cobalt(Ii) and Nickel(Ii) Complexes of 2-Aminothiazole with Demethylcantharate

Crystal Structures, DNA Interaction and Antiproliferative Activities of the Cobalt(ii) and Zinc(ii) Complexes of 2-Amino-1,3,4-thiadiazole with Demethylcantharate

Interaction with Biomacromolecules and Antiproliferative Activities of Mn(Ii), Ni(Ii), Zn(Ii) Complexes of Demethylcantharate and 2,2 '-Bipyridine

Synthesis, interaction with DNA and bovine serum albumin of the transition metal complexes of demethylcantharate and 2-aminobenzothiazole.

Two Novel Cadmium(ii) Complexes with Demethylcantharate and Polypyridyl: Crystal Structure, Interactions with DNA and Bovine Serum Albumin

Aqua(2,2 '-Diamino-4,4 '-Bi-1,3-thiazole-kappa N-2,N ')-(Thiodiacetato-kappa O-3,S,O ')cobalt(ii) Dihydrate

Synthesis,Crystal Structure and Bioactivity of a Pd(Ⅱ) Complex with Demethylcantharate and 2,2'-Bipyridine

Synthesis, Crystal Structure and Antiproliferative Activity of Mn(Ii) Complexes of Demethylcantharate

Synthesis and crystal structure determination of cobalt(II) mixed-ligand complex containing 1,10-phenanthroline and 5-(2-carboxybenzyloxy)isophthalic acid: Their biological evaluation viz. DNA/protein binding profile, pBR322 DNA cleavage activity

Cobalt(II) terpyridine complexes: synthesis, characterization, antiproliferative activity and molecular docking with proteins and DNA

Study on the synthesis, characterization,. Crystal structure and anticancer acitivity of a bridging ligand complex of Cu(II) with 2,2′ -bipyridine and demethylcantharate

Synthesis, Characterization and DNA Binding of the Complexes of Rare Earth with Phenanthroline and Demethylcantharate

Crystal structure, TCPTP inhibition and cytotoxicity of the cobalt(II) complex with the 4‐{[3‐(pyridine‐2‐yl)‐1H‐pyrazol‐1‐yl]methyl}‐benzoic acid ligand

Synthesis, Crystal Structure and Dna Interaction of A Novel Three-Nuclear Cobalt(Ii) Complex with Schiff Base Derived from 4-Chloroanthranilic Acid and 2,4-Dihydroxybenzaldehyde

Synthesis, crystal structure, magnetic property and nuclease activity of a new binuclear cobalt(II) complex.

Cobalt(II) Complexes with Thiosemicarbazone As Potential Antitumor Agents: Synthesis, Crystal Structures, DNA Interactions, and Cytotoxicity

Structure and spectral performance of Co(II) and Co(III) complexes for DNA-binding: Synthesis, characterization and comparison